Sony Interactive Entertainment Inc. et al. v. Resonant Systems, Inc.

IPR2024-00568

Sony Interactive Entertainment's IPR challenge against Resonant Systems was denied by the PTAB, finding that Sony failed to demonstrate a reasonable likelihood of success on any challenged claim. The Board adopted the Patent Owner's view regarding the 'control component,' requiring an algorithmic structure for obviousness.

Jurisdiction
US PTAB
Case Number
IPR2024-00568
Judge(s)
KARL D. EASTHOM, NORMAN H. BEAMER, BRIAN D. RANGE
Decision Date
16 February 2024

Detailed Summary

The Petitioner, Sony Interactive Entertainment Inc., sought Inter Partes Review (IPR) against claims 1–8, 11, and 15–17 of U.S. Patent No. 9369081, alleging obviousness under 35 U.S.C. § 103. The PTAB ultimately denied institution because Sony failed to meet the standard requiring a reasonable likelihood of prevailing on at least one challenged claim. A key element in the dispute was the definition of 'control component,' where the Board sided with Resonant Systems, finding that the prior art did not teach the necessary algorithmic steps required by the patent.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Sony Interactive Entertainment Inc. et al. vs Resonant Systems, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2025-00534

Samsung Electronics America, Inc. et al.vsKoninklijke KPN N.V.

Samsung and Dutch telecom KPN settled their disputes, leading the PTAB to terminate six inter partes review proceedings before any hearing. The settlement agreement is kept confidential under statutory provisions.

patentIPR2025-00026

QIAGEN Sciences, LLCvsTecan Group AG

QIAGEN has filed an IPR petition seeking cancellation of all ten claims of Tecan’s ’357 sequencing patent, arguing that the invention was fully disclosed in earlier barcoding and sequencing literature.

patentIPR2025-01021

Imperative Care, Inc.vsInari Medical, Inc. et al.

The PTAB instituted an inter partes review of Inari Medical’s 11,554,005 patent covering a vacuum aspiration system with hemostasis valve. Petitioner Imperative Care showed a reasonable likelihood of prevailing on at least one claim, especially claim 1, based on obviousness over Garrison, Schaffer and other references.

patentIPR2025-00832

Taiwan Semiconductor Manufacturing Company, Ltd.vsAdvanced Integrated Circuit Process LLC

TSMC’s request for a Director review of the PTAB’s discretionary denial was rejected. The patent owner argues the Director correctly applied the law and that TSMC’s new‑fact and abuse‑of‑discretion theories lack merit.

patentIPR2025-00984

Apple Inc.vsAdvanced Coding Technologies LLC

Apple has filed an IPR petition challenging claims 2‑4 and 11 of U.S. Patent 10,218,995, asserting obviousness over a combination of prior‑art video‑coding references. The petition seeks institution of the review and cancellation of the challenged claims.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call